- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 150 Pages
Global
From €4654EUR$4,850USD£4,024GBP
- Report
- April 2024
- 137 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- May 2024
- 94 Pages
Global
From €5373EUR$5,600USD£4,646GBP
- Report
- May 2024
- 291 Pages
Global
From €5373EUR$5,600USD£4,646GBP
- Report
- May 2024
- 116 Pages
Global
From €5229EUR$5,450USD£4,522GBP
- Report
- May 2024
- 194 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- March 2024
- 143 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- October 2023
- 142 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- December 2023
- 171 Pages
Global
From €3486EUR$3,633USD£3,014GBP
€4980EUR$5,190USD£4,306GBP
- Report
- June 2023
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- February 2024
- 184 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- January 2024
- 188 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 176 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 112 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- February 2024
- 110 Pages
Global
From €4558EUR$4,750USD£3,941GBP
The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more